Manning Anthony M.

Monte Rosa Therapeutics, Inc. · Director

Manning Anthony M. is listed in filings as Director at Monte Rosa Therapeutics, Inc.. This profile follows SEC Form 4 activity through May 22, 2026, including sale activity. Recent filings connect the profile to Monte Rosa Therapeutics, Inc. (GLUE) and Palatin Technologies, Inc. (PTN). The current snapshot covers public activity from Jun 13, 2024 to May 22, 2026. Reported amounts are shown as $180.1K to $150.7K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.

Data sources and methodology

History Trades

CompanyValueActionPriceCurrent Price
Historical insider buys and sells before the latest disclosure date will appear here after more snapshots are available.